BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36539366)

  • 41. Flotillin-2 promotes cell proliferation via activating the c-Myc/BCAT1 axis by suppressing miR-33b-5p in nasopharyngeal carcinoma.
    Liu R; Liu J; Wu P; Yi H; Zhang B; Huang W
    Aging (Albany NY); 2021 Mar; 13(6):8078-8094. PubMed ID: 33744853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PADI4, negatively regulated by miR-335-5p, participates in regulating the proliferation, migration, invasion and radiosensitivity of nasopharyngeal carcinoma cells.
    Wei LN; Luo M; Wang XP; Liang T; Huang CJ; Chen H
    J Biol Regul Homeost Agents; 2021; 35(1):117-129. PubMed ID: 33593046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long noncoding RNA ANCR promotes migration, invasion, EMT progress and stemness of nasopharyngeal carcinoma cells via the miR-4731-5p/NMT1 axis.
    Ma X; Yuan Y; Lu J; Li M; Yu Y; Liu J; Zhou J
    Pathol Res Pract; 2021 Aug; 224():153540. PubMed ID: 34333213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiosensitizer EXO-miR-197-3p Inhibits Nasopharyngeal Carcinoma Progression and Radioresistance by Regulating the AKT/mTOR Axis and HSPA5-mediated Autophagy.
    Jiang J; Tang Q; Gong J; Jiang W; Chen Y; Zhou Q; Aldeen A; Wang S; Li C; Lv W; Du T; Wang X; Long X; Feng X
    Int J Biol Sci; 2022; 18(5):1878-1895. PubMed ID: 35342334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNA SOX2-OT regulates proliferation and metastasis of nasopharyngeal carcinoma cells through miR-146b-5p/HNRNPA2B1 pathway.
    Zhang E; Li X
    J Cell Biochem; 2019 Oct; 120(10):16575-16588. PubMed ID: 31099048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
    Xue MY; Cao HX
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 49. Curcumin Increases Radiosensitivity of Radioresistant Nasopharyngeal Cancer.
    Wang G; Zhu J; Wang Z; Xu Z; Shi Y; Luo L
    Discov Med; 2023 Jun; 35(176):418-428. PubMed ID: 37272108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.
    Xuefang Z; Ruinian Z; Liji J; Chun Z; Qiaolan Z; Jun J; Yuming C; Junrong H
    Technol Cancer Res Treat; 2020; 19():1533033819892251. PubMed ID: 31984860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway.
    Liu F; Tai Y; Ma J
    Cancer Biol Ther; 2018 Jun; 19(6):534-542. PubMed ID: 29565706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
    Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
    Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
    Ji Y; Wang M; Li X; Cui F
    Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.
    Ou H; Li Y; Kang M
    PLoS One; 2014; 9(11):e109929. PubMed ID: 25365510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA HEIH modulates CDK8 expression by inhibiting miR-193a-5p to accelerate nasopharyngeal carcinoma progression.
    Han YE; Tao JM; Wang SX; Ju X; Song ZY
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):770-778. PubMed ID: 33577031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
    Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
    PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-483-5p decreases the radiosensitivity of nasopharyngeal carcinoma cells by targeting DAPK1.
    Tian Y; Yan M; Zheng J; Li R; Lin J; Xu A; Liang Y; Zheng R; Yuan Y
    Lab Invest; 2019 May; 99(5):602-611. PubMed ID: 30664712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-145-5p modulates Krüppel-like factor 5 and inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma.
    Yuan CH; Hsu WC; Huang AM; Yuan BC; Chen IH; Hsu CA; Chen RF; Chu YM; Lin HH; Ke HL
    BMC Mol Cell Biol; 2022 Jul; 23(1):28. PubMed ID: 35836107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway.
    Zhang W; Zhang Q; Cui Q; Xu Y
    Hum Exp Toxicol; 2023; 42():9603271221150248. PubMed ID: 36607163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma.
    Liu YH; Liu JL; Wang Z; Zhu XH; Chen XB; Wang MQ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):622-629. PubMed ID: 30720170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.